Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after ingestion, according to a study published online Dec. 16 in JAMA Network Open.
Manan M. Nayak, Ph.D., from the Dana-Farber Cancer Institute in Boston, and colleagues randomly assigned 50 patients with advanced breast cancer and baseline clinical anxiety to receive oral CBD 400 mg (25 patients) or placebo (25 patients) within 48 hours before a scan assessing tumor burden.
The researchers found that the primary end point of change scores on the afraid subscale of the Visual Analog Mood Scale (VAMS) before and two to four hours after ingestion was numerically greater in the CBD arm, but did not differ significantly between the arms. Significantly lower VAMS afraid T-scores were seen for participants receiving CBD versus placebo when comparing anxiety levels two to four hours after study drug ingestion. There were no reports of grade 3 or 4 toxic effects.
"This preliminary randomized clinical trial establishes CBD as a treatment for anxiety for patients with breast cancer and has laid groundwork for a larger, more definitive trial to test the efficacy of oral CBD, 400 mg, in decreasing anxiety in this patient population," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-21 06:00
Read more

- Coffee Leads U.S. Caffeine Intake as Tea Declines
- 2.3 Million New Female Breast Cancer Cases Seen Globally in 2022
- Blood Test Could Guide Better Diet For Irritable Bowel Syndrome
- FDA Grants Fast Track Designation to PleoPharma, Inc's Investigational New Drug, PP-01, for the Mitigation of Cannabis Withdrawal Symptoms in Patients With Cannabis Use Disorder
- 2020 to 2021 Saw Rise in Firearm-Related Hospitalizations
- As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions